AW

Amaan Waseem

Active Director Director DIN 09860360
DIN 09860360 First appointment Jan 2023 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jan 2023
Shareholding value Locked Premium profile

About Amaan Waseem

Amaan Waseem has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Stalline Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 09860360
Primary Designation Director
First Appointment 13 Jan 2023
Oldest Company Age 3 yrs

Current companies

Company Designation Appointment Founded Status
Stalline Biotech Private Limited U24239UP2023PTC177017
Director 13 Jan 2023 2023 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Stalline Biotech Private Limited
Premium access

Shareholding and investment profile for Amaan Waseem

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amaan Waseem

Amaan Waseem has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Stalline Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

Amaan Waseem is associated with 1 company as Director.

Amaan Waseem has expertise in Technology.

Amaan Waseem has 3 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available